Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

NCT03719690

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +7 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • The Oncology Institute of Hope and Innovation - Anaheim Whittier, California, United States
View all 102 locations
View Trial Details
Completed

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

NCT03666273

Conditions
Advanced Solid Tumor, Carcinoma, Carcinoma, Squamous Cell, +8 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Chicago Hospitals Chicago, Illinois, United States
  • Henry Ford Health System Detroit, Michigan, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

NCT06413095

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations
  • UC Davis Sacramento, California, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States
  • Montefiore Medical Center The Bronx, New York, United States
View Trial Details

Related conditions